Legal
Purdue, Sackler Family Reach New $7.4 Billion Opioid Accord
- Settlement with states to resolve suits over deadly epidemic
- Deal addresses issue in high court’s rejection of earlier pact
This article is for subscribers only.
Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the deadly opioid epidemic.
The deal comes after the US Supreme Court last year rejected a $6 billion pact that would have protected Purdue’s owners, members of the billionaire Sackler family, from any further litigation related to the addiction crisis. Thursday’s settlement in principle doesn’t give the family automatic protection from future litigation, New York Attorney General Letitia James said in a statement.